Status: Recruiting
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
The purpose of this study is to compare the effect of prasugrel plus low-dose aspirin versus high dose aspirin alone (300mg) and versus low dose aspirin alone (75 mg) in patients with chronic coronary disease undergoing coronary artery bypass grafting.
Participants needed: 1,703
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.Updated: Jun 5, 2026Locations: 18
Eligibility criteria
Age >18 years [+8]
Cardiogenic shock [+18]